Mikhailova E, Roumiantseva J, Illarionova O, Lagoyko S, et al. Strong expansion of normal CD19-negative B-cell precursors after the use of blinatumomab in the first-line therapy of acute lymphoblastic leukaemia in children. Br J Haematol 2022;196:e6-e9.
PMID: 34346071